San Diego, CA, United States of America

Jane Seagal

This inventor holds 1 USPTO granted patent and 7 published patent applications and 1 EPO patent. Top assignee: Abbvie Inc.. Active years: 2023.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jane Seagal: Innovator in Antibody Research

Introduction

Jane Seagal is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. Her work is recognized for its potential impact on various medical applications.

Latest Patents

Jane Seagal holds 1 patent for her invention of anti-CCR8 antibodies. This patent includes compositions and methods for using these antibodies, which are crucial in advancing treatment options for certain diseases.

Career Highlights

Jane is currently employed at AbbVie Inc., a global biopharmaceutical company known for its innovative research and development. Her role at AbbVie allows her to work on cutting-edge projects that aim to improve patient outcomes.

Collaborations

Throughout her career, Jane has collaborated with notable colleagues, including Amanda M Schmidt Paustian and Andrew J McCluskey. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Jane Seagal's contributions to antibody research exemplify the innovative spirit of modern science. Her work continues to pave the way for advancements in medical treatments and therapies.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…